PetCaseFinder

Peer-reviewed veterinary case report

Heart disease markers in dogs with systemic inflammatory response

By Gommeren, Kris et al.·Published in Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001)·2019·Department of Clinical Sciences·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Cardiovascular biomarkers in dogs with systemic inflammatory response syndrome.

Species:
dog

Plain-English summary

A group of 69 dogs with systemic inflammatory response syndrome (SIRS) were treated in an emergency department, showing symptoms like difficulty breathing or lethargy. Blood tests revealed that a specific heart protein, cardiac troponin T (cTnT), was significantly higher in dogs that did not survive compared to those that did. While another marker, NT-proBNP, also increased, it did not correlate with survival rates. The findings suggest that high levels of cTnT could indicate a poorer prognosis in dogs with SIRS, helping vets assess the severity of the condition.

People also search for: dog breathing problems SIRS · high troponin levels in dogs · dog heart disease prognosis

Abstract

OBJECTIVE: To measure plasma N-terminal fragments of pro-B-type natriuretic peptides (NT-proBNP) and cardiac troponin T (cTnT) concentration in hospitalized dogs and relate these markers to underlying conditions and evaluate their potential as prognostic markers in dogs with systemic inflammatory response syndrome (SIRS). DESIGN: Prospective, observational, clinical study. SETTING: Emergency department of a university teaching hospital. ANIMALS: Sixty-nine dogs with SIRS examined in the emergency department were prospectively studied. Patient age ranged from 5 months to 15 years, and weight ranged from 5.5 to 75 kg. MEASUREMENTS AND MAIN RESULTS: Blood samples were obtained at presentation, during hospitalization until discharge or death, and at a "control" visit (T1m) at least 1 month after hospital discharge. NT-proBNP was assayed with a commercially available canine ELISA, while cTnT was measured with an automated immunoassay previously used in dogs. A correlation procedure, mixed procedure on a linear model, and a logistic procedure were performed. Forty-four patients survived, 19 of which had control visits. cTnT concentrations were significantly higher than T0 and T1m at T12, T24, and T72. In 28 dogs, cTnT was detected during hospitalization, but cTnT was not detected in any dog at the control visits. Higher concentrations of cTnT were negatively associated with survival, irrespective of disease category. NT-proBNP concentrations were significantly higher than T0, T6, T12, and T1m at T24, T72, and T120, but were not associated with survival. CONCLUSIONS: NT-proBNP and cTnT increased significantly in dogs with SIRS, regardless of the underlying disease process. Nonsurvivors displayed significantly higher cTnT concentrations during hospitalization.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/31034737/